Mulligan AM - Search Results

1

Evaluation of a High-Sensitivity Organ-Targeted PET Camera.

Stiles J, Baldassi B, Bubon O, Poladyan H, Freitas V, Scaranelo A, Mulligan AM, Waterston M, Reznik A. Stiles J, et al. Among authors: mulligan am. Sensors (Basel). 2022 Jun 21;22(13):4678. doi: 10.3390/s22134678. Sensors (Basel). 2022. PMID: 35808181 Free PMC article.

2

The characteristics associated with upgrade on surgical pathology of conventional imaging occult DCIS diagnosed by MRI.

Amitai Y, Menes TS, Scaranelo A, Fleming R, Kulkarni S, Ghai S, Wey L, Mulligan AM, Mrkonjic M, Freitas VAR. Amitai Y, et al. Among authors: mulligan am. Breast Cancer Res Treat. 2021 Nov;190(2):317-327. doi: 10.1007/s10549-021-06372-8. Epub 2021 Sep 2. Breast Cancer Res Treat. 2021. PMID: 34476644

3

Contralateral Breast Screening with Preoperative MRI: Long-Term Outcomes for Newly Diagnosed Breast Cancer.

Freitas V, Li X, Amitai Y, Au F, Kulkarni S, Ghai S, Mulligan AM, Bromley M, Siepmann T. Freitas V, et al. Among authors: mulligan am. Radiology. 2022 Aug;304(2):297-307. doi: 10.1148/radiol.212361. Epub 2022 Apr 26. Radiology. 2022. PMID: 35471109

4

Granular cell tumour of the breast: MRI findings and review of the literature.

Scaranelo AM, Bukhanov K, Crystal P, Mulligan AM, O'Malley FP. Scaranelo AM, et al. Among authors: mulligan am. Br J Radiol. 2007 Dec;80(960):970-4. doi: 10.1259/bjr/95130566. Epub 2007 Oct 16. Br J Radiol. 2007. PMID: 17940129

5

Breast specimen handling and reporting in the post-neoadjuvant setting: challenges and advances.

Mrkonjic M, Berman HK, Done SJ, Youngson B, Mulligan AM. Mrkonjic M, et al. Among authors: mulligan am. J Clin Pathol. 2019 Feb;72(2):120-132. doi: 10.1136/jclinpath-2018-205598. J Clin Pathol. 2019. PMID: 30670564 Review.

6

Patterns of Recurrence and Predictors of Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy, Surgery, and Radiation.

Keilty D, Nezafat Namini S, Swain M, Maganti M, Cil TD, McCready DR, Cescon DW, Amir E, Fleming R, Mulligan AM, Fyles A, Croke JM, Liu FF, Levin W, Koch CA, Han K. Keilty D, et al. Among authors: mulligan am. Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):676-685. doi: 10.1016/j.ijrobp.2020.04.044. Epub 2020 May 11. Int J Radiat Oncol Biol Phys. 2020. PMID: 32407932

7

JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer.

Reedijk M, Pinnaduwage D, Dickson BC, Mulligan AM, Zhang H, Bull SB, O'Malley FP, Egan SE, Andrulis IL. Reedijk M, et al. Among authors: mulligan am. Breast Cancer Res Treat. 2008 Oct;111(3):439-48. doi: 10.1007/s10549-007-9805-3. Epub 2007 Nov 8. Breast Cancer Res Treat. 2008. PMID: 17990101

8

Metastatic potential of encapsulated (intracystic) papillary carcinoma of the breast: a report of 2 cases with axillary lymph node micrometastases.

Mulligan AM, O'Malley FP. Mulligan AM, et al. Int J Surg Pathol. 2007 Apr;15(2):143-7. doi: 10.1177/1066896906299119. Int J Surg Pathol. 2007. PMID: 17478767

9

PGDS, a novel technique combining chromogenic in situ hybridization and immunohistochemistry for the assessment of ErbB2 (HER2/neu) status in breast cancer.

Ni R, Mulligan AM, Have C, O'Malley FP. Ni R, et al. Among authors: mulligan am. Appl Immunohistochem Mol Morphol. 2007 Sep;15(3):316-24. doi: 10.1097/01.pai.0000213138.01536.2e. Appl Immunohistochem Mol Morphol. 2007. PMID: 17721278

10

Prognostic effect of basal-like breast cancers is time dependent: evidence from tissue microarray studies on a lymph node-negative cohort.

Mulligan AM, Pinnaduwage D, Bull SB, O'Malley FP, Andrulis IL. Mulligan AM, et al. Clin Cancer Res. 2008 Jul 1;14(13):4168-74. doi: 10.1158/1078-0432.CCR-07-4543. Clin Cancer Res. 2008. PMID: 18593996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

148 results

Search Page